13 Sep Can AI improve healthcare for everyone?
Will the introduction of AI systems improve diagnosis, treatment, and research, bringing better and fairer healthcare to all? Or not?...
News
08 Sep Trial participants are heroes, let’s treat them that way
Being a clinical trial participant, especially in an interventional trial, is a sacrifice of time and body and represents a true commitment on the part of the patient....
06 Sep The case for loosening trial eligibility reins
Restrictive eligibility criteria has been a concern for many oncology researchers, who believe these trials should reflect a broader real-world population....
03 Sep Preventing Alzheimer’s disease
The UW School of Medicine and Public Health's Dr. Sterling Johnson recently joined Wisconsin Public Radio to discuss the Wisconsin Registry for Alzheimer's Prevention (WRAP) study at the University of Wisconsin-Madison....
31 Aug Pet dogs to the rescue!
Health-related discoveries in people can lead to better medical care for dogs. Likewise, studies of dog biology can lead to better understanding and treatments for people....
31 Aug Senator Baldwin, WEDC Secretary Hughes WIMR tour highlights UW–Madison collaborations, innovations in biohealth
Wisconsin Senator Tammy Baldwin recently visited the Wisconsin Institutes for Medical Research at UW–Madison, highlighting the university’s experience and expertise as a collaborative powerhouse in bioscience and technology....
30 Aug Faster drug approvals by FDA raise concerns about transparency and beneficence in clinical trials
Are faster drug approvals by the FDA hurting the public's overall perception of clinical research?...
29 Aug Psychedelic drug trial guidance: Commenters see vital role for psychotherapy
Commenters on the FDA's guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug administration from psychotherapy support, the proposed credentials for lead safety monitors and the agency’s characterization of the abuse potential of psychedelic drugs....
28 Aug UW–Madison joins state consortium to bolster Wisconsin’s lead in biohealth
UW–Madison has joined a statewide consortium, mobilizing its experience and expertise as a collaborative powerhouse in bioscience and technology to help bolster Wisconsin’s leadership in personalized medicine and biohealth technology....
25 Aug Where are all the Arabs? And how a U.S. Census change could improve clinical trial diversity
Arabs are are often categorized as white in clinical research. Grouping individuals from diverse genetic backgrounds under a single racial category can be problematic in clinical research....